PB
Pankaj Badlani
About Pankaj Badlani
Data last updated:
Pankaj Badlani is a Director at Pure Pharma Limited (since 2019) and Director at Promed Laboratories Private Limited (since 2003). The companies operate in Food and Beverages, Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹6.68 Cr; the largest is Pure Pharma Limited at ₹5.01 Cr (FY 2024). Earlier, Pankaj Badlani was a Director at Pro Laboratories Private Limited (2005–2023) and Director at Pro-Pharma Care Private Limited (2014–2023) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 May 2019 | 1980 | ₹5.01 Cr (FY 2024) | Active | |
| Director | 01 Sep 2003 | 1971 | ₹1.67 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Feb 2005 | 2005 | ₹74.31 Cr (FY 2025) | Active | |
| Director | 25 Mar 2014 | 2012 | ₹38.89 Cr (FY 2024) | Active | |
| Director | 11 Jan 2001 | 1995 | Strike Off | ||
| Director | 22 Jun 2000 | 1994 | Active | ||
| Director | 18 Aug 2006 | 1996 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pankaj Badlani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahesh Badlani | 00070393 | Pure Pharma Limited , Promed Laboratories Private Limited | Director |
| Subhash Rijhwani | 00155029 | Pure Pharma Limited , Promed Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pankaj Badlani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pankaj Badlani
Pankaj Badlani currently holds 2 directorships: Pure Pharma Limited (Director, since 16 May 2019, revenue ₹5.01 Cr (FY 2024)); Promed Laboratories Private Limited (Director, since 01 Sep 2003, revenue ₹1.67 Cr (FY 2025)).
Pankaj Badlani was first appointed on 22 Jun 2000 as Director at Jpbee Investments Pvt Ltd N. The most recent appointment on record is 16 May 2019 at Pure Pharma Limited.
The 2 current companies of Pankaj Badlani that report revenue have a combined latest revenue of ₹6.68 Cr: Pure Pharma Limited ₹5.01 Cr (FY 2024); Promed Laboratories Private Limited ₹1.67 Cr (FY 2025).
Pankaj Badlani held 5 earlier board appointments: Pro Laboratories Private Limited (Director, 15 Feb 2005 to 25 Oct 2023); Pro-Pharma Care Private Limited (Director, 25 Mar 2014 to 25 Oct 2023); S.N.Hingorani Consultants And Investments Pvt Ltd (Director, 11 Jan 2001 to 29 Sep 2011); Jpbee Investments Pvt Ltd N (Director, 22 Jun 2000 to 16 Aug 2018); Cecil Pharmaceuticals Private Limited (Director, 18 Aug 2006 to 28 Feb 2011).
The current boards of Pankaj Badlani's companies include Mahesh Badlani (Pure Pharma Limited), Subhash Rijhwani (Pure Pharma Limited).